Intelligence / Thymosin Alpha-1

Thymosin Alpha-1

Prescription Only
Immune Modulator
Schedule
S4
Prescription Only
Enforcement
Stable
Low Risk
Providers
6
Access: Limited
Key Facts
Schedule 4 - Prescription Only
Thymus-derived immune modulating peptide
6 identified Australian providers
Niche but stable availability
No anticipated regulatory changes

Overview

Thymosin Alpha-1 is a peptide fragment of prothymosin alpha, naturally produced by the thymus gland. It is a niche prescription peptide in Australia, available through select telehealth providers and compounding pharmacies.

Australian Scheduling

Schedule 4 (Prescription Only). Stable classification with no anticipated regulatory changes. Available through standard compounding pharmacy pathways.

Access Pathway

Available through select telehealth providers. 6 identified Australian providers. Not as widely available as growth hormone secretagogues or tissue repair peptides, but access is stable.

Regulatory Notice

For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.

Are You a Practitioner?

List your clinic for free and reach patients actively searching for legal peptide access in Australia.